Seaport Therapeutics Inc (SPTX)

Finanzdaten der Seaport Therapeutics Inc-Aktie (SPTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate
	53.89%30.35	65.81	27.54
Research and Development	2.96%23.89	24.62	21.43
Operating Income/Loss	53.89%-30.35	-65.81	-27.54
Nonoperating Income/Loss	17.90%4.08	3.46	2.65
Income/Loss From Continuing Operations Before Tax	57.87%-26.27	-62.35	-24.89
Income Tax Expense/Benefit	49.40%0.13	0.25	0.52
	57.84%-26.39	-62.60	-25.41
Attributable To Parent	57.84%-26.39	-62.60	-25.41
Basic Average Shares	51.92%53.53	35.24	2.46
Diluted Average Shares	51.92%53.53	35.24	2.46
Basic Earnings Per Share	72.47%-0.49	-1.78	-10.34
Diluted Earnings Per Share	72.47%-0.49	-1.78	-10.34
Common Stock Dividends	-	-	-